main-logo

ICD-10 Code B46.2 | Gastrointestinal mucormycosis Symptoms, Diagnosis, Billing

Gastrointestinal mucormycosis is a severe fungal infection caused by mucormycetes, typically affecting immunocompromised individuals. This condition can lead to significant morbidity and mortality if not promptly diagnosed and treated. The ICD-10 Code B46.2 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this critical condition.

What is ICD-10 Code B46.2 for Gastrointestinal mucormycosis?

ICD-10 Code B46.2 represents gastrointestinal mucormycosis, a life-threatening fungal infection primarily affecting the gastrointestinal tract. This code is used when documenting cases of mucormycosis associated with underlying conditions such as diabetes mellitus or immunosuppression. Accurate use of this code in clinical documentation and billing is essential for appropriate patient management and reimbursement.

ICD-10 Code B46.2 – Clinical Definition and Explanation of Gastrointestinal mucormycosis

Gastrointestinal mucormycosis is caused by the invasion of mucormycetes fungi, often in patients with compromised immune systems. The condition can progress rapidly, leading to severe complications, including bowel necrosis and systemic infection, necessitating urgent medical intervention.

Key Clinical Features:

  • Abdominal pain and distension
  • Nausea and vomiting
  • Gastrointestinal bleeding
  • Fever and systemic signs of infection

ICD-10 Code B46.2 for Gastrointestinal mucormycosis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B46.2 is utilized to document the diagnosis of gastrointestinal mucormycosis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B46.2 for Gastrointestinal mucormycosis Mean in SOAP Notes?

ICD-10 Code B46.2 connects subjective patient reports and objective clinical findings to a formal diagnosis of gastrointestinal mucormycosis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B46.2 – Gastrointestinal mucormycosis

Gastrointestinal mucormycosis requires urgent medical attention and often hospitalization for effective management. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

  • Amphotericin B (first-line) for 4-6 weeks
  • Posaconazole (alternative) for 6-12 months
  • Isavuconazole (alternative) for 6-12 months

Supportive Care:

  • Fluid resuscitation to manage dehydration
  • Nutritional support via enteral or parenteral routes
  • Management of underlying conditions such as diabetes

Infection Control:

  • Strict adherence to hand hygiene
  • Use of personal protective equipment (PPE) in healthcare settings
  • Isolation precautions during outbreaks

How to Document Symptoms of Gastrointestinal mucormycosis (ICD-10 B46.2) in SOAP Notes

Subjective:

  • Patient reports severe abdominal pain
  • Nausea and vomiting present for 3 days
  • History of diabetes mellitus and recent chemotherapy
  • Fever and chills noted by the patient

Objective:

  • Abdominal tenderness on palpation
  • Fever of 101°F
  • Elevated white blood cell count (WBC)
  • Imaging shows bowel wall thickening
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Gastrointestinal mucormycosis (ICD-10 Code B46.2)

Assessment:

  • Diagnosis: Gastrointestinal mucormycosis, severe
  • ICD-10 Code: B46.2
  • Contributing factors: Diabetes mellitus, immunosuppression
  • Potential triggers: Recent chemotherapy

Plan:

  • Initiate amphotericin B therapy
  • Consult infectious disease specialist
  • Monitor renal function and electrolytes
  • Schedule follow-up imaging in one week

Treatment & Plan Section for ICD-10 Code B46.2 – Gastrointestinal mucormycosis

  • First-line treatment with amphotericin B
  • Consider surgical intervention for necrotic tissue
  • Educate patient on signs of worsening condition
  • Regular monitoring of blood glucose levels

Using ICD-10 Code B46.2 for Gastrointestinal mucormycosis in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and history
  • Use B46.2 in conjunction with relevant comorbidity codes
  • Align treatment plans with clinical guidelines for reimbursement
  • Include detailed notes on patient education and follow-up

ICD-10 Code B46.2 in Medical Billing and Insurance for Gastrointestinal mucormycosis

ICD-10 Code B46.2 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings and treatments
  • Use B46.2 in conjunction with other applicable codes
  • Ensure compliance with payer-specific documentation requirements

Common CPT Pairings:

CPT CodeDescription
99223Initial hospital care, typically 70 minutes or more
10060Incision and drainage of abscess, simple
96365Intravenous infusion, for therapeutic, prophylactic, or diagnostic purposes

Frequently Asked Questions

Common Questions About Using ICD-10 Code B46.2 for Gastrointestinal mucormycosis

What are the common symptoms of gastrointestinal mucormycosis?

Common symptoms include severe abdominal pain, nausea, vomiting, fever, and gastrointestinal bleeding. These symptoms often indicate a serious underlying condition requiring immediate medical attention.

How is gastrointestinal mucormycosis diagnosed?

Diagnosis typically involves clinical evaluation, imaging studies, and laboratory tests to identify the presence of mucormycetes. The use of ICD-10 Code B46.2 is essential for accurate documentation and billing.

What is the treatment for gastrointestinal mucormycosis?

Treatment usually involves antifungal therapy, such as amphotericin B, and may require surgical intervention to remove necrotic tissue. Supportive care is also critical for managing symptoms and complications.

Is gastrointestinal mucormycosis contagious?

Gastrointestinal mucormycosis is not contagious; it typically occurs in individuals with weakened immune systems. Preventive measures focus on minimizing exposure to environmental sources of the fungus.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved